Storys aus Switzerland,

Medison Pharma; Alnylam Pharmaceuticals

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

Zug, Switzerland (ots/PRNewswire) - - The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance - Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unified platform for efficient ...

Microsoft Switzerland

Children's Hospital Utilizes Advanced Digital Solutions to Improve Patient Care

Nestlé Nespresso SA

NESPRESSO WILL INVEST 20 MILLION USD IN DRC TO SUPPORT THE COFFEE GROWING COMMUNITY AND THE REVIVAL OF THE SPECIALTY COFFEE

Vevey, Switzerland (ots/PRNewswire) - Focusing on an increased sourcing of high-quality coffee, as well as implementing regenerative practices, gender equality programs and projects to increase access to healthcare and clean water. Nespresso aims to continue to support the local community and economy by investing 20 ...

HARSCH SA

HARSCH increases its operational capacity with the opening of a new secure storage facility in Meyrin

Polaroid Therapuetics

Polaroid Therapeutics completes pre-clinical milestones in the development of superior antimicrobial technology for acute and chronic wounds

Bern, Switzerland (ots/PRNewswire) - - Its proprietary innovative polymer technology reduces bacterial bioburden without triggering antimicrobial resistance, one of the top global public health threats - The Advanced Wound Dressing (AWD) market is valued at 4.5 billion USD and is witnessing increasing demand and ...

SHL Medical

SHL Medical partners with SteriPack Group to set up final assembly service

Zug, Switzerland (ots) - SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership. Together, they aim to establish a pre-validated final assembly service at the SteriPack ...

Anapaya Systems AG

Anapaya, AWS and InterCloud to Expand SCION network access for Swiss Critical Infrastructure Sectors

INFOSYS

Infosys, a Top 3 IT services brand globally. Leads the IT services industry with the fastest CAGR in brand value over 5 years. Infosys' Salil Parekh is the no.1 IT services CEO in Brand Guardianship Index 2024

Davos, Switzerland (ots/PRNewswire) - Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has been recognized as the Top 3 IT services brand globally and the fastest growing IT services brand over a 5 year period, according to ...

Kickfund AG

Launch of Kickfund to boost the Swiss Deep Tech Startup Ecosystem

Medison Pharma

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries

Zug, Switzerland (ots/PRNewswire) - - Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, advanced basal cell carcinoma, advanced non-small cell lung cancer and advanced cervical cancer, and is approved by regulatory ...

Medison Pharma; Ipsen

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Zug, Switzerland and Paris (ots/PRNewswire) - Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, ...

Green Datacenter AG

Green Metro-Campus in Zurich enters next stage of construction / Building work has commenced on two additional Green data centers on the Metro-Campus Zurich

Silony Medical International AG

Silony Medical acquires Centinel Spine's Global Fusion Business

Frauenfeld, Switzerland (ots/PRNewswire) - The transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has signed a definitive agreement to acquire Centinel Spine's Global Fusion Business. This combines Silony's Verticale® posterior screw & rod fusion ...

MAVERICKS Life Co.

Latest Sports & Fitness Innovation: Holistic Training Syllabus by MAVERICKS Life Co.

CRANS-MONTANA, Switzerland (ots/PRNewswire) - Sports science & wellbeing education company, MAVERICKS Life Co., announces the release of its new Holistic Training Syllabus, rooted in evolutionary biology and epigenetics theory. It's a brand new innovation in the sports and fitness sector. Recent scientific studies* have led to groundbreaking development that is ...

Capri Sun

Capri Sun to take over sales and distribution from Coca-Cola Europacific Partners in Western Europe in 2024

Zug, Switzerland (ots/PRNewswire) - Capri Sun Group Holding AG, the no. 1 kids drink brand in the world, has announced today that it will take back the sales and distribution of its iconic pouch drinks in France, Monaco, Great Britain, Netherlands, Belgium, Luxemburg, Sweden, Spain, and Portugal in 2024, bringing to ...

Géza Anda-Stiftung

16th Concours Géza Anda 2024 - Jury, Rules, Repertoire

Klarpay AG

Klarpay AG Supports Young Athletes in Swiss Youth Olympic Sailing

Zug, Switzerland (ots/PRNewswire) - Klarpay AG, a leading global payments solution provider, is delighted to announce its partnership with Janut Angehrn and Julie Herzig, part of the Swiss Youth Olympic Sailing talent pool, as their official sponsor. This sponsorship is a testament to Klarpay's commitment to corporate social responsibility. As a proud Swiss company, Klarpay AG recognises the potential and dedication ...

Debiopharm International SA

DEBIOPHARM SHARES ONCOLOGY PROGRAM UPDATES AT ASCO 2023 FOR NOVEL WEE1 INHIBITOR, AND FIRST-IN-CLASS CA IX THERANOSTIC APPROACH

Lausanne, Switzerland (ots) - - Debiopharm will highlight diversified approaches and commitment to improving outcomes for patients with cancer at the 2023 American Society of Clinical Oncology Conference - A poster presentation and discussion will cover promising interim results with Debio 0123, a potent, highly ...

Debiopharm International SA

DEBIOPHARM LAUNCHES PHASE 1 RESEARCH IN SMALL CELL LUNG CANCER WITH WEE1 INHIBITOR DEBIO 0123 TO OUTSMART DDR IN SMALL CELL LUNG CANCER

Lausanne, Switzerland (ots) - - Debiopharm combines its potent WEE1-inhibitor Debio 0123 with standard-of-care therapy to short-circuit DNA damage repair (DDR) in adults with recurrent or progressive small cell lung cancer (SCLC). - The first patient dosed at Vall d’Hebron Hospital (Barcelona, Spain), was ...

Debiopharm International SA

Debiopharm Partners with Genedata to Digitalize Translational Research

Basel, Switzerland (ots) - Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy. Genedata, the leading provider of enterprise software solutions ...

FDI World Dental Federation

FDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT ON WORLD ENVIRONMENT DAY TO HIGHLIGHT SUSTAINABLE DENTAL PRACTICES FOR A GREENER FUTURE

Debiopharm International SA

DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM

Lausanne, Switzerland (ots/PRNewswire) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and ...

Debiopharm International SA

DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCiTM STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM

Lausanne, Switzerland (ots) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and treatment of ...

Medison Pharma; Alnylam Pharmaceuticals

Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics

Zug, Switzerland (ots/PRNewswire) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their ...

Debiopharm International SA

Iktos raises € 15.5m Series A round to expand its artificial intelligence-based drug discovery technologies and solutions

Paris, France and Lausanne Switzerland (ots) - ● The round is co-led by M Ventures and Debiopharm Innovation Fund with Omnes Capital; all joining as new investors ● Series A will enable Iktos to expand its AI technology platform and launch Iktos Robotics; an AI-driven automated end-to-end drug discovery service ...

Debiopharm International SA

DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY

Lausanne, Switzerland (ots) - Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases, today announced having ...

Firmenich

DSM And Firmenich Have Obtained Competition Clearance from the European Commission

Kaiseraugst, Switzerland, Heerlen, Netherlands and Geneva (ots/PRNewswire) - This is a joint press release by Koninklijke DSM N.V. (DSM), Firmenich International SA (Firmenich) and Danube AG, to be renamed DSM-Firmenich AG (the Company) in connection with the voluntary public exchange offer by the Company for all the issued and outstanding ordinary shares in the share ...

Glion Institute of Higher Education

Glion Institute of Higher Education and ESSEC Business School launch a new program: the Global Executive Master's in Hospitality Leadership

Montreux, Switzerland and PARIS-LA Defense (ots/PRNewswire) - Glion Institute of Higher Education, a benchmark business school specializing in hospitality and luxury professions; and ESSEC Business School, a leading management institution, are joining forces to offer a Global Executive Master's degree in Hospitality ...

Landis+Gyr

Icelandic ON Power Scales up EV Charging Service Offering with Landis+Gyr Charge Point Management System

Cham, Switzerland (ots/PRNewswire) - Etrel, a Landis+Gyr company, and ON Power, an Icelandic electricity supplier and charging service provider, cooperate on scaling the company's EV charging service offering in Iceland with the help of the charge point management system OCEAN. ON Power, a charging service provider ...

Firmenich

ACCEPTANCE PERIOD FOR EXCHANGE OFFER EXTENDED PENDING COMPETITION CLEARANCES

Kaiseraugst, Switzerland, Heerlen, Netherlands and Geneva (ots/PRNewswire) - THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS This is a joint press ...